POLYCLONAL ANTIBODY AGAINST HISTONE H3 LYSINE 18 ACETYLATION
UCLA Technology Available For Licensing
INNOVATION:
Researchers at UCLA have developed a polyclonal antibody that specifically recognized histone H3 lysine 18 acetylation.
The antibody has been tested and confirmed to work properly in multiple assays including western blotting, immunofluorescence, immunoprecipitation, flow cytometry and chromatin immunoprecipitation (ChIP) in both human cells and yeast.
Reference: UCLA Case No. 2009-306
For additional technical details and current licensing availability,
please contact the following UCLA office: